These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 34126054)

  • 1. Perplexing mortality data from triple therapy trials in COPD.
    Suissa S
    Lancet Respir Med; 2021 Jul; 9(7):684-685. PubMed ID: 34126054
    [No Abstract]   [Full Text] [Related]  

  • 2. Evaluating the Impact of Triple Therapy on Mortality in Copd: The End is the Beginning?
    Kostikas K; Kyriakopoulos C; Gogali A
    COPD; 2022; 19(1):57-60. PubMed ID: 35050797
    [No Abstract]   [Full Text] [Related]  

  • 3. [Asthma and COPD: guidance in the jungle of inhalative drugs].
    Hering T
    MMW Fortschr Med; 2015 May; 157(10):59, 61-2. PubMed ID: 26019099
    [No Abstract]   [Full Text] [Related]  

  • 4. Role of Long-Acting Muscarinic Antagonist/Long-Acting β
    Petite SE
    Ann Pharmacother; 2017 Aug; 51(8):696-705. PubMed ID: 28410560
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and Safety of Single-inhaler Triple Therapy Containing Dual Bronchodilator With Corticosteroids Compared to Monotherapy, Dual Therapy, or Open Triple Therapy in Moderate/Severe COPD: A Systematic Literature Review.
    Riesco Miranda JA; Calle Rubio M; Díaz Pérez D; López-Campos JL; Trigueros Carrero JA; Celli B
    Arch Bronconeumol; 2024 Jan; 60(1):55-58. PubMed ID: 37985278
    [No Abstract]   [Full Text] [Related]  

  • 6. The reasons for triple therapy in stable COPD patients in Japanese clinical practice.
    Miyazaki M; Nakamura H; Takahashi S; Chubachi S; Sasaki M; Haraguchi M; Terai H; Ishii M; Fukunaga K; Tasaka S; Soejima K; Asano K; Betsuyaku T;
    Int J Chron Obstruct Pulmon Dis; 2015; 10():1053-9. PubMed ID: 26082629
    [TBL] [Abstract][Full Text] [Related]  

  • 7. What is the role of triple inhaled therapy in COPD?
    Petite SE
    JAAPA; 2019 Oct; 32(10):44-45. PubMed ID: 31567741
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhaled corticosteroids in COPD: the final verdict is….
    Leung JM; Sin DD
    Eur Respir J; 2018 Dec; 52(6):. PubMed ID: 30545961
    [No Abstract]   [Full Text] [Related]  

  • 9. Current Controversies in the Pharmacological Treatment of Chronic Obstructive Pulmonary Disease.
    Singh D; Roche N; Halpin D; Agusti A; Wedzicha JA; Martinez FJ
    Am J Respir Crit Care Med; 2016 Sep; 194(5):541-9. PubMed ID: 27585383
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dual bronchodilation vs triple therapy in the "real-life" COPD DACCORD study.
    Buhl R; Criée CP; Kardos P; Vogelmeier CF; Kostikas K; Lossi NS; Worth H
    Int J Chron Obstruct Pulmon Dis; 2018; 13():2557-2568. PubMed ID: 30197512
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Drugs for chronic obstructive pulmonary disorder].
    Bakke PS; Høines KJ
    Tidsskr Nor Laegeforen; 2019 Oct; 139(14):. PubMed ID: 31592602
    [No Abstract]   [Full Text] [Related]  

  • 12. Efficacy of Budesonide/Glycopyrronium/Formoterol Fumarate Metered Dose Inhaler (BGF MDI) Versus Other Inhaled Corticosteroid/Long-Acting Muscarinic Antagonist/Long-Acting β
    Ferguson GT; Darken P; Ballal S; Siddiqui MK; Singh B; Attri S; Holmgren U; de Nigris E
    Adv Ther; 2020 Jun; 37(6):2956-2975. PubMed ID: 32335859
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhaled treatment for chronic obstructive pulmonary disease: what's new and how does it fit?
    Currie GP; Lipworth BJ
    QJM; 2016 Aug; 109(8):505-12. PubMed ID: 26559079
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Single vs Multiple Inhaler Triple Therapy in the COPD Population.
    Cho EE; Gershon AS
    Chest; 2022 Nov; 162(5):947-948. PubMed ID: 36344117
    [No Abstract]   [Full Text] [Related]  

  • 15. Dual LABA/LAMA Therapy versus LABA or LAMA Monotherapy for Chronic Obstructive Pulmonary Disease. A Systematic Review and Meta-analysis in Support of the American Thoracic Society Clinical Practice Guideline.
    Mammen MJ; Pai V; Aaron SD; Nici L; Alhazzani W; Alexander PE
    Ann Am Thorac Soc; 2020 Sep; 17(9):1133-1143. PubMed ID: 32530702
    [No Abstract]   [Full Text] [Related]  

  • 16. LAMA/LABA vs ICS/LABA in the treatment of COPD in Japan based on the disease phenotypes.
    Hizawa N
    Int J Chron Obstruct Pulmon Dis; 2015; 10():1093-102. PubMed ID: 26089659
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic obstructive pulmonary disease: Useful medications for patients with recurrent symptoms.
    Prescrire Int; 2016 Nov; 25(176):272-277. PubMed ID: 30715829
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Future of Triple Therapy in chronic obstructive pulmonary disease.
    Alcázar-Navarrete B; Castellano Miñán F; Romero Palacios PJ
    Arch Bronconeumol (Engl Ed); 2018 Feb; 54(2):63-64. PubMed ID: 28760570
    [No Abstract]   [Full Text] [Related]  

  • 19. Pharmacological treatment of stable COPD: need for a simplified approach.
    Hillas G; Papaporfyriou A; Dimakou K; Papaioannou AI
    Postgrad Med; 2020 Mar; 132(2):126-131. PubMed ID: 31852408
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current evidence for COPD management with dual long-acting muscarinic antagonist/long-acting β
    Skolnik NS; Nguyen TS; Shrestha A; Ray R; Corbridge TC; Brunton SA
    Postgrad Med; 2020 Mar; 132(2):198-205. PubMed ID: 31900019
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.